Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Acute myeloid leukemia 💬
[1] KIT 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
2 Acute myeloid leukemia 💬
[1] KIT 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
3 AGE-RAGE signaling pathway in diabetic complications 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
4 Axon guidance 💬
[1] ABL1 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
5 Axon guidance 💬
[1] ABL1 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
6 Bladder cancer 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
7 Breast cancer 💬
[1] KIT 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
8 Breast cancer 💬
[1] KIT 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
9 Cadherin signaling 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
10 Cadherin signaling 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
11 Calcium signaling pathway 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
12 Calcium signaling pathway 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
13 Calcium signaling pathway 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
14 Cell cycle 💬
[1] ABL1 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
15 Cell cycle 💬
[1] ABL1 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
16 Central carbon metabolism in cancer 💬
[2] KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
17 Central carbon metabolism in cancer 💬
[2] KIT, PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
18 Chemical carcinogenesis - reactive oxygen species 💬
[1] ABL1 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
19 Chemical carcinogenesis - reactive oxygen species 💬
[1] ABL1 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
20 Chemical carcinogenesis - reactive oxygen species 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
21 Chemical carcinogenesis - receptor activation 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
22 Choline metabolism in cancer 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
23 Choline metabolism in cancer 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
24 Chronic myeloid leukemia 💬
[1] ABL1 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
25 Chronic myeloid leukemia 💬
[1] ABL1 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
26 Endocytosis 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
27 Endocytosis 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
28 ErbB signaling pathway 💬
[1] ABL1 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
29 ErbB signaling pathway 💬
[1] ABL1 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
30 Fluid shear stress and atherosclerosis 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
31 Focal adhesion 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
32 Focal adhesion 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
33 Focal adhesion 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
34 Gap junction 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
35 Gap junction 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
36 Glioma 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
37 Glioma 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
38 Hematopoietic cell lineage 💬
[1] KIT 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
39 Hematopoietic cell lineage 💬
[1] KIT 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
40 HIF-1 signaling pathway 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
41 Human cytomegalovirus infection 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
42 Human cytomegalovirus infection 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
43 Human cytomegalovirus infection 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
44 Human papillomavirus infection 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
45 IgSF CAM signaling 💬
[1] ABL1 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
46 IgSF CAM signaling 💬
[1] ABL1 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
47 Integrin signaling 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
48 Integrin signaling 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
49 Integrin signaling 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
50 JAK-STAT signaling pathway 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
51 JAK-STAT signaling pathway 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
52 Kaposi sarcoma-associated herpesvirus infection 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
53 MAPK signaling pathway 💬
[2] KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
54 MAPK signaling pathway 💬
[2] KIT, PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
55 MAPK signaling pathway 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
56 Melanogenesis 💬
[1] KIT 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
57 Melanogenesis 💬
[1] KIT 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
58 Melanoma 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
59 Melanoma 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
60 MicroRNAs in cancer 💬
[2] ABL1, PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
61 MicroRNAs in cancer 💬
[2] ABL1, PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
62 MicroRNAs in cancer 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
63 Neurotrophin signaling pathway 💬
[1] ABL1 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
64 Neurotrophin signaling pathway 💬
[1] ABL1 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
65 Pancreatic cancer 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
66 Pathogenic Escherichia coli infection 💬
[1] ABL1 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
67 Pathogenic Escherichia coli infection 💬
[1] ABL1 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
68 Pathways in cancer 💬
[3] ABL1, KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
69 Pathways in cancer 💬
[3] ABL1, KIT, PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
70 Pathways in cancer 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
71 Phospholipase D signaling pathway 💬
[2] KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
72 Phospholipase D signaling pathway 💬
[2] KIT, PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
73 PI3K-Akt signaling pathway 💬
[2] KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
74 PI3K-Akt signaling pathway 💬
[2] KIT, PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
75 PI3K-Akt signaling pathway 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
76 Prostate cancer 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
77 Prostate cancer 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
78 Proteoglycans in cancer 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
79 Rap1 signaling pathway 💬
[2] KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
80 Rap1 signaling pathway 💬
[2] KIT, PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
81 Rap1 signaling pathway 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
82 Ras signaling pathway 💬
[3] ABL1, KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
83 Ras signaling pathway 💬
[3] ABL1, KIT, PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
84 Ras signaling pathway 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
85 Regulation of actin cytoskeleton 💬
[1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
86 Regulation of actin cytoskeleton 💬
[1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
87 Relaxin signaling pathway 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
88 Renal cell carcinoma 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
89 Rheumatoid arthritis 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
90 VEGF signaling pathway 💬
[1] VEGFA 💬 Bevacizumab 💬 Bevacizumab [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
91 Viral myocarditis 💬
[1] ABL1 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
92 Viral myocarditis 💬
[1] ABL1 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬